Worm medication fights resistant lung cancer

A recent study concluded that combining an anti-parasitic drug with targeted therapy can slow the growth of resistant tumors in mice. The results indicated that this integrated approach may enhance the effectiveness of cancer treatments, and researchers hope to develop it into a new option for treating resistant tumors in the future.